IFI27L2

gene
On this page

Also known as TLH29

Summary

IFI27L2 (interferon alpha inducible protein 27 like 2, HGNC:19753) is a protein-coding gene on chromosome 14q32.12, encoding Interferon alpha-inducible protein 27-like protein 2 (Q9H2X8). Plays a role in the apoptotic process and has a pro-apoptotic activity.

Predicted to enable molecular adaptor activity. Involved in apoptotic process. Located in mitochondrial membrane.

Source: NCBI Gene 83982 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 31 total — 1 pathogenic
  • MANE Select transcript: NM_032036

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:19753
Approved symbolIFI27L2
Nameinterferon alpha inducible protein 27 like 2
Location14q32.12
Locus typegene with protein product
StatusApproved
AliasesTLH29
Ensembl geneENSG00000119632
Ensembl biotypeprotein_coding
OMIM611319
Entrez83982

Gene structure

Transcript identifiers

Ensembl transcripts: 12 — 8 protein_coding, 4 retained_intron

ENST00000238609, ENST00000553601, ENST00000554909, ENST00000555558, ENST00000556552, ENST00000556727, ENST00000940074, ENST00000940075, ENST00000940076, ENST00000940077, ENST00000940078, ENST00000940079

RefSeq mRNA: 1 — MANE Select: NM_032036 NM_032036

CCDS: CCDS9920

Canonical transcript exons

ENST00000238609 — 4 exons

ExonStartEnd
ENSE000010983659412955894129604
ENSE000034831039412851494128675
ENSE000036170459412778194127992
ENSE000036431019412926294129291

Expression profiles

Bgee: expression breadth ubiquitous, 137 present calls, max score 98.87.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 39.7417 / max 212.5914, expressed in 1773 samples.

FANTOM5 promoters (5 alternative TSS)

Promoter IDTPM avgSamples expressed
14467936.85531772
1446801.2083803
1446770.7155456
1446780.6472350
1446810.3154167

Top tissues by expression

137 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
C1 segment of cervical spinal cordUBERON:000646998.87gold quality
substantia nigraUBERON:000203898.80gold quality
hypothalamusUBERON:000189898.68gold quality
temporal lobeUBERON:000187198.55gold quality
amygdalaUBERON:000187698.55gold quality
Ammon’s hornUBERON:000195498.33gold quality
right adrenal glandUBERON:000123398.19gold quality
right adrenal gland cortexUBERON:003582798.14gold quality
left adrenal gland cortexUBERON:003582597.93gold quality
left adrenal glandUBERON:000123497.88gold quality
nucleus accumbensUBERON:000188297.82gold quality
anterior cingulate cortexUBERON:000983597.82gold quality
apex of heartUBERON:000209897.71gold quality
putamenUBERON:000187497.63gold quality
Brodmann (1909) area 9UBERON:001354097.58gold quality
pituitary glandUBERON:000000797.39gold quality
caudate nucleusUBERON:000187397.34gold quality
dorsolateral prefrontal cortexUBERON:000983497.31gold quality
monocyteCL:000057697.25gold quality
leukocyteCL:000073897.14gold quality
adenohypophysisUBERON:000219697.13gold quality
tibial nerveUBERON:000132397.12gold quality
ascending aortaUBERON:000149697.11gold quality
thoracic aortaUBERON:000151597.11gold quality
brainUBERON:000095597.08gold quality
cerebral cortexUBERON:000095697.05gold quality
adrenal glandUBERON:000236997.05gold quality
right frontal lobeUBERON:000281096.97gold quality
right atrium auricular regionUBERON:000663196.97gold quality
left ovaryUBERON:000211996.96gold quality

Single-cell (SCXA)

Detected in 4 experiment(s), a significant marker in 3.

ExperimentMarker?Max mean expression
E-ANND-3yes11.94
E-CURD-112yes5.81
E-HCAD-10yes4.36
E-GEOD-125970no8.69

Regulation

Is transcription factor: no

Cross-species orthologs

0 orthologs

Paralogs (3): IFI6 (ENSG00000126709), IFI27L1 (ENSG00000165948), IFI27 (ENSG00000165949)

Protein

Protein identifiers

Interferon alpha-inducible protein 27-like protein 2Q9H2X8 (reviewed: Q9H2X8)

Alternative names: Interferon-stimulated gene 12b protein, Protein TLH29, pIFI27-like protein

All UniProt accessions (2): Q9H2X8, A0A0B4J270

UniProt curated annotations — full annotation on UniProt →

Function. Plays a role in the apoptotic process and has a pro-apoptotic activity.

Subcellular location. Mitochondrion membrane.

Induction. Not up-regulated by type-I interferon.

Similarity. Belongs to the IFI6/IFI27 family.

RefSeq proteins (1): NP_114425* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR009311IFI6/IFI27-likeFamily
IPR038213IFI6/IFI27-like_sfHomologous_superfamily

Pfam: PF06140

UniProt features (5 total): transmembrane region 3, chain 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9H2X8-F154.730.00

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 145 (showing top): HUMMERICH_MALIGNANT_SKIN_TUMOR_DN, BOYLAN_MULTIPLE_MYELOMA_D_DN, FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN, MARTINEZ_RB1_TARGETS_UP, GOBP_APOPTOTIC_SIGNALING_PATHWAY, INGRAM_SHH_TARGETS_UP, YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6, GOCC_MITOCHONDRIAL_ENVELOPE, GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY, MARTINEZ_RB1_AND_TP53_TARGETS_UP, HAN_JNK_SINGALING_UP, chr14q32, NUYTTEN_EZH2_TARGETS_DN, CASTELLANO_NRAS_TARGETS_UP, COLINA_TARGETS_OF_4EBP1_AND_4EBP2

GO Biological Process (2): apoptotic process (GO:0006915), intrinsic apoptotic signaling pathway (GO:0097193)

GO Molecular Function (1): molecular adaptor activity (GO:0060090)

GO Cellular Component (3): mitochondrion (GO:0005739), mitochondrial membrane (GO:0031966), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
apoptotic signaling pathway2
programmed cell death1
execution phase of apoptosis1
intracellular signal transduction1
molecular_function1
binding1
cytoplasm1
intracellular membrane-bounded organelle1
mitochondrion1
mitochondrial envelope1
organelle membrane1
cellular anatomical structure1

Protein interactions and networks

STRING

690 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
IFI27L2RSAD2Q8WXG1405
IFI27L2IFIT5Q13325394
IFI27L2IFITM10A6NMD0365
IFI27L2TMEM168Q9H0V1327
IFI27L2ISG15P05161323
IFI27L2TLCD1Q96CP7318
IFI27L2IFITM2Q01629316
IFI27L2OCEL1Q9H607314
IFI27L2IRF1P10914314
IFI27L2IFIH1Q9BYX4313
IFI27L2GOLGB1Q14789312
IFI27L2A0A2U3TZT1A0A2U3TZT1310
IFI27L2IFI44LQ53G44305
IFI27L2IFITM3Q01628301
IFI27L2MX1P20591294

IntAct

7 interactions, top by confidence:

ABTypeScore
FCN1IFI27L2psi-mi:“MI:0915”(physical association)0.370
TFAP2AIFI27L2psi-mi:“MI:0915”(physical association)0.370
TFAP2CIFI27L2psi-mi:“MI:0915”(physical association)0.370
IFI27L2TFAP2Cpsi-mi:“MI:0915”(physical association)0.370
CELF1IFI27L2psi-mi:“MI:0915”(physical association)0.000
IFI27L2psi-mi:“MI:0915”(physical association)0.000

ESM2 similar proteins: A0A0H2XIV9, A0L9X3, B0KTG9, B1I892, B5E1Z4, B8ZNI6, C0HL68, C1C9E8, C1CGA6, C1CMJ2, C1CTB2, O26106, O31557, P07579, P09912, P0A3K0, P0A3K1, P0C8T8, P0DTW2, P0DY15, P19407, P34306, P34327, P34677, P40843, P58316, P67293, P67294, P75617, P77354, P80967, P83313, P84841, P86018, P86155, Q04IS6, Q18EC3, Q24JY7, Q28808, Q2G179

Diamond homologs: P09912, P40305, Q24JY7, Q28808, Q6IED8, Q8R412, Q8VC49, Q96BM0, Q9H2X8

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

31 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance19
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
443977GRCh37/hg19 14q11.2-32.33(chr14:20511673-107285437)Pathogenic

SpliceAI

351 predictions. Top by Δscore:

VariantEffectΔscore
14:94128671:CAGGG:Cacceptor_gain1.0000
14:94128673:GGG:Gacceptor_gain1.0000
14:94128674:GG:Gacceptor_gain1.0000
14:94128675:GCTG:Gacceptor_loss1.0000
14:94128676:C:CAacceptor_loss1.0000
14:94128676:C:CCacceptor_gain1.0000
14:94129556:A:ACdonor_gain1.0000
14:94129557:C:CCdonor_gain1.0000
14:94129557:CT:Cdonor_gain1.0000
14:94129557:CTCAT:Cdonor_gain1.0000
14:94129561:T:Cdonor_gain1.0000
14:94128507:CACT:Cdonor_loss0.9900
14:94128508:ACTTA:Adonor_loss0.9900
14:94128509:CTTA:Cdonor_loss0.9900
14:94128510:TTA:Tdonor_loss0.9900
14:94128511:T:TGdonor_loss0.9900
14:94128512:A:ACdonor_gain0.9900
14:94128512:AC:Adonor_gain0.9900
14:94128513:C:CCdonor_gain0.9900
14:94128513:C:CTdonor_loss0.9900
14:94128513:CC:Cdonor_gain0.9900
14:94128513:CCCA:Cdonor_gain0.9900
14:94128672:AGGG:Aacceptor_gain0.9900
14:94128675:GCTGT:Gacceptor_gain0.9900
14:94129554:TCACT:Tdonor_loss0.9900
14:94129555:CACTC:Cdonor_loss0.9900
14:94129556:ACT:Adonor_gain0.9900
14:94129557:C:Adonor_loss0.9900
14:94129557:CTC:Cdonor_gain0.9900
14:94129557:CTCA:Cdonor_gain0.9900

AlphaMissense

809 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
14:94128629:G:CF28L0.994
14:94128629:G:TF28L0.994
14:94128631:A:GF28L0.994
14:94128539:G:CS58R0.980
14:94128539:G:TS58R0.980
14:94128541:T:GS58R0.980
14:94128630:A:GF28S0.978
14:94128597:G:TA39E0.969
14:94128630:A:CF28C0.966
14:94128634:C:GG27R0.963
14:94128584:C:AM43I0.953
14:94128584:C:GM43I0.953
14:94128584:C:TM43I0.953
14:94128603:G:AS37F0.949
14:94128521:C:AQ64H0.941
14:94128521:C:GQ64H0.941
14:94129265:C:GG12R0.938
14:94129265:C:TG12R0.938
14:94128531:G:TA61D0.932
14:94128573:G:TA47D0.932
14:94128633:C:TG27D0.929
14:94127944:C:TG83E0.928
14:94128525:A:GL63P0.928
14:94128634:C:AG27C0.928
14:94128615:A:GI33T0.927
14:94128603:G:TS37Y0.925
14:94128615:A:TI33N0.924
14:94128520:A:GS65P0.922
14:94128633:C:AG27V0.919
14:94128645:A:TL23H0.919

dbSNP variants (sampled 300 via entrez): RS1000319698 (14:94131205 C>A), RS1000604153 (14:94129832 C>G), RS1001074417 (14:94129380 G>A,T), RS1001845754 (14:94129740 GCTTGA>G), RS1002440470 (14:94128740 C>G), RS1002752441 (14:94128334 C>A,G), RS1003022745 (14:94129824 A>C), RS1004738859 (14:94128791 A>G), RS1004849379 (14:94129680 G>A,C,T), RS1006112101 (14:94130858 G>A,T), RS1006963403 (14:94130651 AT>A,ATT), RS1007272932 (14:94130344 C>G,T), RS1007420959 (14:94129533 A>G), RS1009284928 (14:94127953 G>A), RS1009290828 (14:94129348 G>A,T)

Disease associations

OMIM: gene MIM:611319 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

29 total (human), top 29 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneaffects methylation, increases expression4
sodium arseniteincreases expression2
Cisplatinaffects expression, increases expression2
Estradioldecreases expression2
Tetrachlorodibenzodioxinincreases expression2
GSK-J4decreases expression1
dicrotophosdecreases expression1
ethyl-p-hydroxybenzoatedecreases expression1
methylparabendecreases expression1
avobenzoneincreases expression1
di-n-butylphosphoric acidaffects expression1
chloropicrindecreases expression1
jinfukangincreases expression1
(+)-JQ1 compounddecreases expression1
bisphenol AFdecreases expression1
Irinotecanaffects cotreatment, increases expression1
Temozolomidedecreases expression1
Decitabineaffects expression1
Sunitinibdecreases expression1
Air Pollutantsdecreases expression, increases abundance1
Arsenicaffects methylation1
Doxorubicinincreases expression1
Fluorouracilincreases expression, affects cotreatment1
Rotenoneincreases expression1
Smokedecreases expression1
Tobacco Smoke Pollutionincreases expression1
Cadmium Chlorideincreases expression1
Okadaic Aciddecreases expression1
Particulate Matterdecreases expression, increases abundance1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.